-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Deudextromethorphan Hydrobromide + Quinidine Sulfate) in Dementia Associated With Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Deudextromethorphan Hydrobromide + Quinidine Sulfate) in Dementia Associated With Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Deudextromethorphan Hydrobromide + Quinidine Sulfate)...
-
Product Insights
NewNet Present Value Model: Otsuka Holdings Co Ltd’s (Deudextromethorphan hydrobromide + Quinidine sulfate)
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Otsuka Holdings Co Ltd's (Deudextromethorphan hydrobromide + Quinidine sulfate) Drug Details: AVP-786 is under development for the treatment of agitation associated with dementia of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deuruxolitinib Phosphate in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deuruxolitinib Phosphate in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Deuruxolitinib Phosphate in Alopecia Areata Drug Details: Deuruxolitinib phosphate (CTP-543, Deuterated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Deudextromethorphan Hydrobromide + Quinidine Sulfate) in Dementia Associated With Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Deudextromethorphan Hydrobromide + Quinidine Sulfate) in Dementia Associated With Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Deudextromethorphan Hydrobromide + Quinidine...
-
Product Insights
Medical Imaging Information Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Medical Imaging Information Systems Pipeline Market Report Overview Medical imaging information systems are used in hospitals and diagnostic imaging centers to store, retrieve, modify, and forward images and information to hospital departments or imaging centers over a network. The Medical Imaging Information Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Company Profile
Concert Pharmaceuticals Inc – Company Profile
Concert Pharmaceuticals Inc (Concert Pharma) is a late-stage clinical biotechnology company. It discovers and develops drugs for impacted patient care and addresses medical needs. The company develops its products using its deuterated chemical entity (DCE) platform for the treatment of autoimmune dermatological conditions, which includes alopecia areata. The alopecia areata occurs when the immune system attacks the hair follicles and is characterized as non-scarring hair loss. It also develops CTP-543, which is an oral inhibitor of Janus kinases JAK1 and...
Add to Basket -
Product Insights
Net Present Value Model: Deuruxolitinib Phosphate
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Deuruxolitinib Phosphate Drug Details Deuruxolitinib phosphate...
-
Product Insights
Net Present Value Model: PCS-499
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model PCS-499 Drug Details PCS-499 (deuterated S-lisofylline,...
-
Product Insights
Net Present Value Model: (Deudextromethorphan hydrobromide + Quinidine sulfate)
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model (Deudextromethorphan hydrobromide + Quinidine sulfate) Drug...